Investigation of the Inhibition Effect of SP600125 +Capecitabine+Oxaliplatin on Gastric Cancer Cell Line GSC7901

Shao-qun LIU,Yi CHEN,Jian-fa WANG,Yi-ou CAO

DOI: https://doi.org/10.3969/j.issn.1006-2084.2016.23.038

2016-01-01

Abstract:Objective To explore the involvement of c-Jun N-terminal kinase (JNK) signaling pathway in the inhibition of gastric cancer cell line GSC7901 by SP600125 +capecitabine+oxaliplatin,and provide references for the development of novel medicine for tumor .Methods Gastric cancer cell line GSC7901 in good growth state were randomly divided into 5 groups:control group, SP600125 +oxaliplatin group ( SP600125 10 μmol/L+oxaliplatin 25 μmol/L) ,SP600125+capecitabine group( SP600125 10 μmol/L+capecitabine 50 μmol/L),SP600125 +capecitabine +oxaliplatin group(SP600125 10 μmol/L +capecit-abine 25 μmol/L+oxaliplatin 50 μmol/L) and SP600125 group (SP600125 10 μmol/L).The inhibition rate of proliferation was detected by MTT method .The apoptotic related protein and JNK signaling pathway proteins were detected by Real-time PCR and Western Blotting .Results There was an obvious inhibition effect on the proliferation of gastric cancer cells at 12 h,24 h,48 h and 72 h in the SP600125 +oaliplatin group,SP600125 +capecitabine group, SP600125 +capecitabine +oxaliplatin group and SP600125 group cells signified.The differences between groups,time points and groups· time points interaction were statisti-cally significant(P<0.05).The expression of caspase 3,caspase 9,Bax mRNA were higher while Bcl-2 mRNA was lower in SP600125+capecitabine+oxaliplatin group than in the control group ,SP600125 group, SP600125+capecitabine group and SP600125+oxaliplatin group(P<0.05).The expression of caspase-3, caspase-9,Bax proteins were higher while Bcl-2 protein was lower in SP600125 +capecitabine +oxaliplatin group than in control group,SP600125 group,SP600125 +capecitabine group and SP600125 +oxaliplatin group (P<0.05).After the treatment of medication,the JNK1 and JNK2 expression were expressed at the same level in SP600125+capecitabine+oxaliplatin group and the SP600125+oaliplatin group,SP600125+capecitabine group,SP600125 group and control group(P>0.05).At the same time,the pJNK1 expression was lower in the SP600125 +capecitabine +oxaliplatin group than in the control group,SP600125 group, SP600125+capecitabine group and SP600125+oxaliplatin group(P<0.05).The pJNK2 expression in the SP600125+capecitabine+oxaliplatin group was higher than the SP600125 group while lower than the con-trol group,SP600125+capecitabine group and SP600125+oxaliplatin group(P<0.05).The result showed that the expression of PERK,IRE1,Bip and CHOP were higher in the SP600125+capecitabine+oxaliplatin group than in the control group,SP600125 group,SP600125+capecitabine group and SP600125+oxaliplatin group (P<0.05).Conclusion SP600125+capecitabine+oxaliplatin can inhibit the proliferation and pro-mote the apoptosis of gastric cell line GSC7901 possibly by activating the JNK phosphorylation.